| Jeffrey T Roith, DPM | |
|
10550 Quivira Rd, Ste 360, Overland Park, KS 66215-2379 | |
| (913) 894-4040 | |
| (913) 438-4725 |
| Full Name | Jeffrey T Roith |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 35 Years |
| Location | 10550 Quivira Rd, Overland Park, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285728527 | NPI | - | NPPES |
| 16317091 | Other | BCBS KC | |
| 490218 | Other | KS | BCBS |
| 16317081 | Other | BCBS-KANSAS CITY | |
| 302968300 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 000626 (Missouri) | Secondary |
| 213E00000X | Podiatrist | 12-00235 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Luke's South Hospital | Overland park, KS | Hospital |
| Overland Park Reg Med Ctr | Overland park, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas City Institute Of Podiatry Pa | 1759649650 | 3 |
News Archive
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
Researchers have discovered that specific cancer-causing genes associated with leukemias can transform mature white blood cells into leukemic cells that have all the properties of stem cells.
They're a double-edged sword for nursing home residents and staff – making it easier and safer to handle a basic bodily function, but putting frail patients in danger of infections that can lead to confusion, falls and death.
A new survey, released today (22 March 2016) by the Royal Medical Benevolent Fund, highlights the overwhelming concern amongst doctors about the state of their mental health and wellbeing as a result of working under increasing pressure and scrutiny.
A healthcare.gov website data delivery glitch is keeping insurers from fully enrolling people. In the meantime, HHS is asking insurers to allow consumers to pay premiums late and to let them temporarily see doctors who may not be on their health plans.
› Verified 4 days ago
| Provider Name | Kansas City Institute Of Podiatry Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184135584 PECOS PAC ID: 1759649650 Enrollment ID: O20171226001089 |
News Archive
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
Researchers have discovered that specific cancer-causing genes associated with leukemias can transform mature white blood cells into leukemic cells that have all the properties of stem cells.
They're a double-edged sword for nursing home residents and staff – making it easier and safer to handle a basic bodily function, but putting frail patients in danger of infections that can lead to confusion, falls and death.
A new survey, released today (22 March 2016) by the Royal Medical Benevolent Fund, highlights the overwhelming concern amongst doctors about the state of their mental health and wellbeing as a result of working under increasing pressure and scrutiny.
A healthcare.gov website data delivery glitch is keeping insurers from fully enrolling people. In the meantime, HHS is asking insurers to allow consumers to pay premiums late and to let them temporarily see doctors who may not be on their health plans.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey T Roith, DPM 10550 Quivira Rd, Ste 360, Overland Park, KS 66215-2379 Ph: (913) 894-4040 | Jeffrey T Roith, DPM 10550 Quivira Rd, Ste 360, Overland Park, KS 66215-2379 Ph: (913) 894-4040 |
News Archive
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
Researchers have discovered that specific cancer-causing genes associated with leukemias can transform mature white blood cells into leukemic cells that have all the properties of stem cells.
They're a double-edged sword for nursing home residents and staff – making it easier and safer to handle a basic bodily function, but putting frail patients in danger of infections that can lead to confusion, falls and death.
A new survey, released today (22 March 2016) by the Royal Medical Benevolent Fund, highlights the overwhelming concern amongst doctors about the state of their mental health and wellbeing as a result of working under increasing pressure and scrutiny.
A healthcare.gov website data delivery glitch is keeping insurers from fully enrolling people. In the meantime, HHS is asking insurers to allow consumers to pay premiums late and to let them temporarily see doctors who may not be on their health plans.
› Verified 4 days ago
Visiting Podiatry Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 9393 W 110th St, Suite 500, Office 557, Overland Park, KS 66210 Phone: 913-800-6973 Fax: 855-342-0434 | |
Foot Care Plus Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 9218 Metcalf Ave # 287, Overland Park, KS 66212 Phone: 816-225-2557 Fax: 816-434-5748 | |
Jeffrey T Roith Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 10600 Quivira Rd, Suite 220, Overland Park, KS 66215 Phone: 913-894-4040 Fax: 913-438-4725 | |
Kansas City Institute Of Podiatry, P.a. Podiatrist Medicare: Medicare Enrolled Practice Location: 10550 Quivira Rd Ste 360, Overland Park, KS 66215 Phone: 913-894-4040 | |
Ali R Davis, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4601 W 109th St Ste 314, Overland Park, KS 66211 Phone: 913-364-1314 Fax: 913-364-1160 | |
Comprehensive Foot Centers P.a. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 11413 Ash St, Overland Park, KS 66211 Phone: 816-455-1155 Fax: 816-455-1161 | |
Mark E Landry, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 10550 Quivira Rd, Suite 260, Overland Park, KS 66215 Phone: 913-438-9898 Fax: 913-438-9899 |